Skip to main navigation Skip to search Skip to main content

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

  • Michal Lotem*
  • , Sharon Merims
  • , Stephen Frank
  • , Tamar Hamburger
  • , Aviram Nissan
  • , Luna Kadouri
  • , Jonathan Cohen
  • , Ravid Straussman
  • , Galit Eisenberg
  • , Shoshana Frankenburg
  • , Einat Carmon
  • , Bilal Alaiyan
  • , Shlomo Shneibaum
  • , Zeynep Ozge Ayyildiz
  • , Murat Isbilen
  • , Kerem Mert Senses
  • , Ilan Ron
  • , Hanna Steinberg
  • , Yoav Smith
  • , Eitan Shiloni
    • Ali Osmay Gure, Tamar Peretz
*Corresponding author for this work
  • Hadassah University Medical Centre
  • Weizmann Institute of Science
  • Tel Aviv Sourasky Medical Center
  • Bilkent University
  • Hebrew University of Jerusalem
  • Bnai-Zion Medical Center

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology